Patent details

EP2694552 Title: NOVEL EGFR BINDING PROTEINS

Basic Information

Publication number:
EP2694552
PCT Application Number:
US2012032519
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127237683
PCT Publication Number:
WO2012138997
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NOVEL EGFR BINDING PROTEINS
French Title of Invention:
NOUVELLE PROTÉINE SE LIANT À EGFR
German Title of Invention:
NEUE EGFR-BINDENDE PROTEINE
SPC Number:

Dates

Filing date:
06/04/2012
Grant date:
11/10/2017
EP Publication Date:
12/02/2014
PCT Publication Date:
11/10/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/10/2017
EP B1 Publication Date:
11/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/04/2018
Expiration date:
06/04/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/10/2017
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Inventor

Name:
GUO, Amy
Address:
United States (US)

Priority

Priority Number:
201161473014 P
Priority Date:
07/04/2011
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28;

Publication

European Patent Bulletin

Issue number:
201741
Publication date:
11/10/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/08/2018 Outgoing Correspondence 1